
BacTech is a publicly listed Canadian company with its shares quoted on the TSX Venture Exchange (Symbol: BM). The Company was founded in 1988 with its origin in Western Australia. BacTech was incorporated in mid 1997 in Ontario, Canada, and went public in September of the same year.
The Company owns proprietary bacterial oxidation technology that liberates precious and base metals from difficult to treat sulphide ores and concentrates. Bacterial oxidation is a safe and environmentally friendly process. It has the advantage of improving metal recovery at significantly lower capital and operating costs when compared to the traditional treatment methods of smelting, roasting and pressure oxidation. BacTech is a proven leader in the commercialization of bacterial oxidation technology in the metal extractive industry. BacTech's business plan involves identifying projects with difficult metallurgy. Should the project be amenable to bioleaching, BacTech will strive to acquire an equity position in the project. BacTech will also entertain a conventional licensing transaction, should equity in the project be unavailable. |